Emerging Technology Program Quality - Oct. 16-17, 2019

Emerging Technology Program (18of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

FDA Research Supporting Emerging Technologies with Case Studies (24of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

Emerging Technology Program

U.S. Food and Drug Administration

The Importance of Quality in Our Medicines (2of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

Panel Questions and Discussion (22of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

Panel Questions and Discussion (26of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

Panel Questions and Discussion (6of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

Keynote: CDER’s Commitment to Pharmaceutical Quality (1of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

EMERGING TECHNOLOGY ( Course 4 )

IDEAS Project at Cosmopolitan

Quality Assessment of BLAs, NDAs, and ANDAs (3of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

Policy Considerations for Continuous Manufacturing (19of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

Application Manufacturing Assessment (4of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

Panel Questions and Discussion (33of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

Quality Metrics, Quality Culture, and Data-Driven Decisions (16of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

Assessment of the Multi-Attribute Method (MAM) Substance (23of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

ICH Q12 Guidance and Emerging Technology Program (11of16) Generic Drugs Forum 2020

U.S. Food and Drug Administration

Data Quality Expectations for Biosimilars with Case Studies (29of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

End-to-end Integrated Continuous Manufacturing (25of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

Policy Initiatives for Pharmaceutical Quality (5of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration

FDA’s Quality Assessment and Knowledge Management - KASA (11of33) Quality – Oct. 16-17, 2019

U.S. Food and Drug Administration